FDA Inspection 848258 — Genzyme Polyclonals S.A.S.

Genzyme Polyclonals S.A.S. — FEI 3002650449

The FDA completed an inspection of Genzyme Polyclonals S.A.S. on Jan 14, 2013 in Marcy l Etoile. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 14, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Marcy l Etoile (France)